SB 2772 Illinois Senate · 104th Regular Session

PSILOCYBIN ADVISORY BOARD

Summary
Creates the Illinois Psilocybin Advisory Board Act. Sets forth findings and defines terms. Establishes the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation for the purpose of advising and making recommendations to the Department regarding the provision of psilocybin and psilocybin services. Sets forth requirements for members of the Board. Provides that, within 3 months after the effective date of the Act, the Governor, the Senate President, the Speaker of the House, the Minority Leader of the House, and the Minority Leader of the Senate shall appoint certain individuals to the Board. Provides that, between January 1, 2027 and January 1, 2029, the Board shall meet at least once every 2 calendar months at a time and place determined by the chairperson or a majority of the voting members of the Board and that, after January 1, 2029, the Board shall meet at least once every calendar quarter. Provides that the Board shall perform certain duties, including publishing an annual report describing the Board's activities and making recommendations concerning (i) the safety and efficacy of psilocybin and other substances, (ii) potential requirements for providing psilocybin services to clients, (iii) a potential code of ethics and possible training requirements for facilitators, and (iv) public health considerations. Makes other changes. Effective immediately.
Bill status passed 3 of 5 stages cleared
Introduction
May 2026
Committee Review
May 2026
Senate Passage
May 2026
House Passage
Governor
Introduced May 8, 2026 Last action May 15, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Engrossed · 4 edits · May 7, 2026
MODERATE
The bill was updated to expand the definition of regulated substances to include ayahuasca and synthetically produced psilocybin, and to clarify that psilocybin products can be synthetically derived. Additionally, the text was revised to specify that psilocybin's safety and efficacy depend on appropriate treatment protocols, and the list of federally recognized breakthrough therapies was slightly adjusted to match specific FDA language.
Scope change
The bill's scope was broadened to include ayahuasca and synthetically produced psilocybin under the regulated substances list, and the definition of 'psilocybin product' was expanded to explicitly cover synthetic versions.
DEFINITION

Added 'ayahuasca' to the list of regulated entheogens and 'lysergic acid diethylamide' to the list of substances.

Added 'synthetically produced psilocybin or psilocin' to the definition of 'psilocybin product'.

Added the condition 'when used with the appropriate treatment protocols' to the finding regarding psilocybin's safety and efficacy.

Adjusted the description of FDA actions to specify that the Breakthrough Therapy designation was granted for a treatment using psilocybin.

Floor votes · Senate May 7, 2026

How they voted

4013
Passed · 5 other
Total votes 58
May 7, 2026
D Democratic39
36 Yea 3
92% Yea
R Republican19
4 Yea 13 Nay 2
68% Nay
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
48
Key actions
5
Committee
11
Amendments
11
May 15, 2026
Committee
Rule 19(a) / Re-referred to Rules Committee
lower
May 12, 2026
Lower · Passed
Motion Filed to Suspend Rule 21 Executive Committee; Rep. Robyn Gabel
lower
May 12, 2026
Lower · Passed
Committee Deadline Extended-Rule 9(b) May 15, 2026
lower
May 12, 2026
Committee
Assigned to Executive Committee
lower
May 12, 2026
Committee
Referred to Rules Committee
lower
May 8, 2026
Introduced
Arrived in House
lower
May 7, 2026
Amended
Senate Floor Amendment No. 1 Tabled Pursuant to Rule 5-4(a)
upper
May 7, 2026
Upper · Passed
Third Reading - Passed; 041-013-000
upper
May 7, 2026
Upper · Passed
Senate Floor Amendment No. 3 Adopted; Ventura
upper
May 7, 2026
Amended
Senate Floor Amendment No. 2 Tabled Ventura
upper
Apr 30, 2026
Introduced
Senate Floor Amendment No. 3 Recommend Do Adopt Executive; 009-004-000
upper
Apr 28, 2026
Introduced
Senate Floor Amendment No. 3 Assignments Refers to Executive
upper
Apr 21, 2026
Committee
Senate Floor Amendment No. 3 Referred to Assignments
upper
Apr 21, 2026
Introduced
Senate Floor Amendment No. 3 Filed with Secretary by Sen. Rachel Ventura
upper
Apr 15, 2026
Introduced
Senate Floor Amendment No. 2 Recommend Do Adopt Executive; 009-004-000
upper
Apr 15, 2026
Introduced
Senate Floor Amendment No. 2 Assignments Refers to Executive
upper
Apr 14, 2026
Committee
Senate Floor Amendment No. 2 Referred to Assignments
upper
Apr 14, 2026
Introduced
Senate Floor Amendment No. 2 Filed with Secretary by Sen. Rachel Ventura
upper
Apr 14, 2026
Introduced
Senate Floor Amendment No. 1 Assignments Refers to Executive
upper
Apr 13, 2026
Committee
Senate Floor Amendment No. 1 Referred to Assignments
upper
Apr 13, 2026
Introduced
Senate Floor Amendment No. 1 Filed with Secretary by Sen. Rachel Ventura
upper
Mar 11, 2026
Upper · Passed
Do Pass Executive; 009-003-000
upper
Feb 3, 2026
Committee
Assigned to Executive
upper
Jan 13, 2026
Committee
Referred to Assignments
upper
2 primary · 13 co-sponsors

Sponsors